RIL
RCKT icon

Rothschild Investment LLC’s Rocket Pharmaceuticals RCKT Stock Holding History

Rothschild Investment LLC’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37K Buy
1,863
+931
+100% +$3.1K ﹤0.01% 2145
2026
Q1 		$3.34K Buy
932
+901
+2,906% +$3.58K ﹤0.01% 2275
2025
Q4 		$109 Buy
+31
New +$106 ﹤0.01% 3196
2025
Q2 		– Sell
-160
Closed -$1.07K – 3155
2025
Q1 		$1.07K Buy
160
+65
+68% +$642 ﹤0.01% 2299
2024
Q4 		$1.19K Buy
95
+70
+280% +$1.05K ﹤0.01% 2105
2024
Q3 		$462 Buy
25
+5
+25% +$102 ﹤0.01% 2493
2024
Q2 		$431 Buy
20
+15
+300% +$345 ﹤0.01% 2110
2024
Q1 		$135 Buy
+5
New +$142 ﹤0.01% 1992

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Rothschild Investment LLC's RCKT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Rocket Pharmaceuticals (RCKT) stake by 100% in Q2 2026, buying an estimated $3.1K and bringing the position to 1,863 shares worth $6.37K. The position accounts for ﹤0.01% of the portfolio, ranked #2145.

Rothschild Investment LLC first reported a position in RCKT in Q1 2024 and has held it in 8 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Rothschild Investment LLC held 1,863 shares of Rocket Pharmaceuticals worth $6.37K as of Q2 2026.
  • Rothschild Investment LLC bought 931 Rocket Pharmaceuticals shares in Q2 2026, an estimated $3.1K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2145 holding.
  • Rothschild Investment LLC first reported a position in Rocket Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.